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PAR-2 levels and modulation in human normal and osteoarthritic 
cartilage and synovial membrane as well as its role in the in situ 
synthesis of catabolic factors. The effects of PAR-2 on metallo- 
protease (MMP)-I and cyclooxygenase (COX)-2 production were 
evaluated. 
Methods: PAR-2 levels were determined using immunohis- 
tochemistry. The protein modulation was investigated on os- 
teoarthritic tissue explants treated for 48 hours as follows: for 
cartilage and synovial membrane with a PAR-2 activating peptide 
(400 I~M), IL-11~ (100 pg/ml) or TNFo~ (5 ng/ml); and for cartilage 
with a specific inhibitor of MEK1/2, PD 98059 (10 I~M), p38, SB 
202190 (10 I~M), NF-KB, SN50 (50 I~M), or COX-2, NS-398 (10 
I~M). MMP-1 and COX-2 production were also evaluated following 
stimulation using the PAR-2 activating peptide. 
Results: PAR-2 is produced in both human cartilage and syn- 
ovial membrane; its expression is significantly increased in os- 
teoarthritic tissues compared to normal (p<0.03). PAR-2 produc- 
tion is significantly upregulated by IL-11~, TNFo~, and PAR-2 acti- 
vating peptide in both articular tissues. The PAR-2 activating pep- 
tide also markedly induces MMP-1 and COX-2 production. Inter- 
estingly, only the specific p38 inhibitor, SB 202190, was able to 
down-regulate PAR-2. 
Conclusion: This study documents that PAR-2 is present at 
increased levels in human osteoarthritic artilage and synovial 
membrane, and identifies the major signaling pathway regulating 
its synthesis. We also demonstrated, for the first time, that the 
specific PAR-2 stimulation can activate major pathophysiological 
pathways of the disease such as the synthesis of MMP and COX- 
2. These results suggest PAR-2 as a potential new therapeutic 
target for the treatment of inflammation in osteoarthritis. 
BL. WORMS scores were rescaled to a range of 0-15 to allow 
comparability of odds ratios (OR) for an increase of 1 unit. 
MRI findings were common, with CRT and any bone lesion (BMA, 
CYS or ATR) each in over 50% of N KP knees. Lesion scores were 
highly correlated within (R=0.50-0.77), but not between, compart- 
ments. Higher scores for nearly all lesions in both TFCs were 
associated with KPO (table) and PKP (not shown), while lesions 
in the PFC were weakly or not associated with KPO and PKP. 
Lateral TFC findings, especially bone lesions, were stronger pre- 
dictors of KPO, while predictors of PKP were similar by TFC. SYN 
and LIG had modest associations (OR 1.1 to 1.5) with KPO and 
PKR 
Odds ratios (95% CI) for KPO and PKP 
MRI Medial TFC Lateral TFC PFC 
Univar for KPO (vs NKP) 
OST 1.3 (1.1, 1.5) 1.6 (1.3, 1.9) 1.3 (1.1, 1.5) 
CRT 1.1 (1.0, 1.2) 1.3 (1.1, 1.5) 1.1 (1.0, 1.2) 
BMA 1.4 (0.9, 2.3) 1.8 (1.1, 3.0) 1.2 (1.0, 1.4) 
CYS 1.9 (1.3, 2.9) 2.2 (1.3, 3.9) 1.2 (0.9, 1.6) 
ATR 1.0 (0.7, 1.4) 1.8 (1.3, 2.5) 1.0 (0.8, 1.2) 
MEN 1.2 (1.0, 1.3) 1.4 (1.2, 1.6) 
Multivar for KPO (vs NKP) 
TOTAL 1.2 (0.9, 1.6) 1.7 (1.2, 2.4) 1.1 (0.9, 1.3) 
Multivar for PKP (vs KPR) 
TOTAL 1.3 (1.1, 1.5) 1.4 (1.2, 1.8) 1.1 (1.0, 1.4) 
Despite a high prevalence of MRI findings in knees of elderly sub- 
jects, higher lesion scores in TFCs at baseline predict both the 
onset of KP and the persistence of KP over 4 years follow-up. 
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OA knee pain (KP) varies over time and it is not known whether 
knee abnormalities assessed by MRI predict longitudinal patterns 
of KP. We used 5 annual assessments of KP in elderly subjects 
to identify knees with common patterns of KP occurrence and 
evaluate baseline (BL) MRI predictors of these patterns. 
1028 participants (62% female; 39% Afr-Am) age 71-80 in the 
Health ABC study had BL knee MRI (1.5 T) and KP assessments 
at BL and 4 annual follow-ups (FU). Axial, coronal and sagittal 
(fat suppressed) T2-weighted FSE sequences were scored using 
WORMS for cartilage damage (CRT), osteophytes (OST), bone 
marrow abnormality (BMA), bone cysts (CYS) and bone attrition 
(ATR) in tibiofemoral (TFC) and patellofemoral (PFC) compart- 
ments; meniscal lesions (MEN) in TFCs; ligament damage (LIG) 
and synovial distention (SYN). Scores summing all lesions in a 
compartment were calculated. A positive report of KP at a visit 
was defined as pain on most days of a month in the past year, or 
_> moderate pain in the past 30 days by WOMAC. Of knees with 
both WORMS and KP data, 410 had no KP (NKP) at any visit, 
88 had KP onset (KPO) after BL, 219 had persistent KP (PKP) 
at all visits and 223 had KP that resolved (KPR) after BL. Lo- 
gistic regression with GEE was used to evaluate MRI predictors 
of KPO (vs. NKP) and of PKP (vs. KPR), adjusting for age, sex, 
race, clinic, smoking, NSAID use, BMI, and contralateral KP at 
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Aim of Study: Little is known of pain over time in knee os- 
teoarthritis (OA). We evaluated the change in pain over 6-9 years 
in a meniscectomy population enriched in subjects with early- 
stage or established knee OA. 
Methods: We evaluated 263 patients with no cruciate ligament 
injury with the validated and self-administered Knee injury and 
Osteoarthritis Outcome Score (KOOS) (table 1). The 1st evalua- 
tion was performed 13-22 years after isolated meniscal resection 
and the 2 nd (2004) after 19-32 years (followup rate 70%). The in- 
terval between the assessments was 6-9 years. A change of _> 10 
KOOS points was considered clinically relevant. Standing semi- 
flexed tibiofemoral and skyline patellofemoral radiographs from 
the 1 st assessment were graded according to the OARSI atlas. 
We considered radiographic OA to be present if any of the fol- 
lowing was found in a knee compartment: JSN grade 2 or higher, 
sum of the 2 marginal osteophyte grades _> 2, or grade 1 JSN in 
combination with a grade 1 osteophyte in the same compartment. 
Results: Radiographic OA at the 1 st assessment was present in 
134/263 (51%) index knees. Subjects with radiographic knee OA 
at entry had more knee pain at both the 1 st and 2ndassessment 
(mean -9.1 and -13.6 KOOS points) compared with individuals 
with no radiographic knee OA (p _< 0.005). Subjects with knee 
OA at entry reported increased knee pain (p < 0.001), subjects 
without OA did not (p = 0.06, figure 1 ). There were 16/46 subjects 
with radiographic knee OA that remained pain free compared with 
36/56 of those without radiographic OA (p = 0.11). Of the 6 sub- 
jects with arthroplastic surgery during the observation period, 3 
individuals reported less pain, the other 3 subjects reported sim- 
ilar or worse (lower) scores. The daily use (at 2 nd assessment) of 
$20 Podium Presentations 
Subject characteristics at 1st assessment 
Radiographic OA No radiographic OA 
n=134 n=129 
Age (mean years) 53.6 50.4 
Sex (% women) 25 16 
BMI (mean kg/m 2) 26.9 25.5 
Time between 1st and 2nd 
assessment (mean years) 7.7 7.4 
Increase in pain considered 
clinically relevant (% subjects) 37 22 
Change in KOOS pain score 
(mean; 95% CI) -7; -3.4, -10.7 -2.5; 0.3, -5.4 
BMI = body mass index, KOOS = Knee injury and Osteoarthritis Outcome 
Score 
over-the-counter drugs, NSAID, or glucosamine sulphate for knee 
pain was more frequent in subjects who reported a clinically rele- 
vant increase in knee pain (_>10 KOOS points) than subjects who 
did not (16% vs. 6%; P = 0.008). 
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Fig. 1. Change in the Knee injury and Osteoarthritis Outcome Score (KOOS) 
for the dimension pain. Patients are divided into subjects with and without ra- 
diographic knee OA at the 1st assessment, but also 3 subgroups according 
to the score at entry. Each line represents 1 patient visualizing the score 
at the 1st assessment (left endpoint of line) and the 2nd assessment in 
2004 (right endpoint of the same line). Please note, several lines showing 
no change in pain (100-100) overlap. 
Conclusions: Over a period of 6-9 years, nearly 40% of menis- 
cectomized subjects with radiographic knee OA report worsening 
in knee pain that is considered clinically relevant. Increased knee 
pain was mostly seen in subjects who were pain free at entry. 
The young age of this cohort constitutes a strong reason to di- 
rect increased efforts toward prevention and better treatment of 
meniscal injury and knee OA. 
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In previous studies, we demonstrated that activation of discoidin 
domain receptor 2 (DDR2, a cell membrane tyrosine kinase), 
which binds preferentially to type II collagen, induces high lev- 
els of expression of MMP-13 in chondrocytes, but not other car- 
tilage matrix-degrading proteinases. We also found that inhibi- 
tion of MEK by PD98059 reduced the expression of MMP-13 in 
human chondrocytes cultured on type II collagen-coated plates, 
suggesting involvement of the Ras/Raf/MEK/ERK pathway. To 
further characterize this response, we performed the following 
experiments. 1) Human chondrocytes were transfected with a 
full-length cDNA of human Raf kinase inhibitor protein (hRKIP) 
and cultured on type II collagen-coated plates for 24 h. Results 
showed that M M P - 13 m R NA levels, examined by real-tim e PC R, 
were reduced about 60% in chondrocytes overexpressing hRKIP 
compared with cells expressing the empty vector control. 2) We 
examined the phosphorylation of three kinases, ERK, JNK and 
p38, in human chondrocytes after culture on type II collagen- 
coated plates for 2 h. Only ERK was phosphorylated further sug- 
gesting the DDR2-mediated response to type II collagen occurs 
via the ERK pathway. 3) Human chondrocytes were transfected 
with the MMP-13 promoter-luciferase construct cultured on type 
II collagen-coated plates for 24 h. Results showed that the MMP- 
13 promoter activity was increased by about 2-fold, suggesting 
that DDR2 response is at least partially transcriptional. 4) Human 
chondrocytes were first treated for 4 h with either an activating or 
a neutralizing alpha2betal integrin antibody and then cultured on 
plastic or type II collagen-coated plates for 24 h. Results showed 
that activating alpha2betal integrin antibody, which did not induce 
DDR2, and type II collagen had a synergistic (additive) effect 
in the induction of MMP-13 mRNA levels, suggesting that type 
II collagen-dependent DDR2 and alpha2betal integrin regulate 
MMP-13 expression through different signaling pathways. In sum- 
mary, this study provides further evidence that activation of DDR2 
increases the expression of MMP-13 via the Ras/Raf/MEK/ERK 
pathway in chondrocytes. 
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Aim of Study: The study was performed to elucidate the mech- 
anism(s) involved in the dedifferentiation in monolayer cultured 
adult human articular chondrocytes. 
Methods: The study was performed under the approval of insti- 
